Ethic Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ethic Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$7,144,775
+12.9%
461,847
+14.6%
0.25%
+6.8%
Q2 2023$6,329,592
+8.0%
402,902
+13.2%
0.24%
-1.3%
Q1 2023$5,863,240
+27.5%
355,779
+20.7%
0.24%
-4.0%
Q4 2022$4,599,007
+154.7%
294,808
+111.7%
0.25%
+101.6%
Q3 2022$1,806,000
-19.0%
139,246
-12.3%
0.12%
-20.6%
Q2 2022$2,230,000
-36.9%
158,863
-35.6%
0.16%
-36.5%
Q1 2022$3,532,000
+85.3%
246,628
+76.3%
0.24%
+66.0%
Q4 2021$1,906,000
+30.0%
139,865
+56.3%
0.15%
-2.0%
Q3 2021$1,466,000
+28.6%
89,481
+32.1%
0.15%
+8.7%
Q2 2021$1,140,000
+9.0%
67,733
+18.2%
0.14%
-25.8%
Q1 2021$1,046,000
+59.9%
57,295
+59.4%
0.19%
+7.5%
Q4 2020$654,000
+2.8%
35,945
+0.9%
0.17%
-28.8%
Q3 2020$636,000
+30.1%
35,630
+30.6%
0.24%
-12.6%
Q2 2020$489,000
+45.1%
27,284
+22.9%
0.28%
-1.1%
Q1 2020$337,000
-6.4%
22,196
+21.7%
0.28%
+6.0%
Q4 2019$360,00018,2390.26%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2020
NameSharesValueWeighting ↓
Glenview Capital Management 16,104,222$294,063,0004.98%
GMT CAPITAL CORP 2,468,695$45,078,0003.31%
MANAGED ASSET PORTFOLIOS, LLC 1,065,756$19,461,0003.13%
Blackcrane Capital, LLC 14,571$1,723,0002.72%
BFAM Partners (Cayman) Ltd 328,690$6,002,0002.36%
Paulson & Co. 4,727,415$86,323,0001.98%
Mondrian Investment Partners LTD 3,510,404$59,677,0001.28%
Lumbard & Kellner, LLC 135,550$2,264,0000.80%
DAVIDSON INVESTMENT ADVISORS 500,203$9,134,0000.78%
TFG Asset Management GP Ltd 589,390$10,762,0000.77%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders